FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

GlaxoSmithKline Arranon Recall

Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I

GlaxoSmithKline, LLC. · Zebulon, NC

Risk level
Class II
Reported by FDA
Dec 5, 2012
Recall ID
D-068-2013
Check your lot numberHow we source this data

Summary

GlaxoSmithKline recalled Arranon starting Oct 8, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-068-2013 on Dec 5, 2012. Reason: Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits. Status: Terminated.

Why it was recalled

Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.

Product description

Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06

Lot numbers, UPCs & expiration codes

Lot # C536707 Exp 02/14, C538830 Exp.02/14, C533169 Exp. 02/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-068-2013
Classification
Class II
Status
Terminated
Recall initiated
Oct 8, 2012
FDA report date
Dec 5, 2012
Quantity
1,319 vials
Recall type
Voluntary: Firm initiated
Recalling firm
GlaxoSmithKline, LLC.

Original FDA data

Every field from FDA enforcement report D-068-2013, exactly as published.

Show all FDA fields
City
Zebulon
State
NC
Status
Terminated
Country
United States
Event ID
63691
Address
1011 North Arendell Ave
Code information
Lot # C536707 Exp 02/14, C538830 Exp.02/14, C533169 Exp. 02/14
Postal code
27597-1217
Report date
Dec 5, 2012
Product type
Drugs
Recall number
D-068-2013
Classification
Class II
Recalling firm
GlaxoSmithKline, LLC.
Product quantity
1,319 vials
Termination date
Sep 11, 2014
Reason for recall
Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06
Distribution pattern
Nationwide
Recall initiation date
Oct 8, 2012
Initial firm notification
Letter
Center classification date
Nov 27, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-068-2013, published Dec 5, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls